ABN AMRO Bank N.V.
Source: SEC Form 13F · as of Mar 2026ABN AMRO Bank N.V. holds 19 biotech & pharma companies tracked by BioSniper, totaling $1.05B in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$1.05B
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 2,445,171 | $482.2M |
| LLYELI LILLY & Co | 239,700 | $221.2M |
| ABBVAbbVie Inc. | 864,389 | $189.8M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 118,349 | $53.3M |
| GILDGILEAD SCIENCES, INC. | 195,724 | $27.5M |
| DGXQuest Diagnostics Incorporated | 94,640 | $18.7M |
| MRKMerck & Co., Inc. | 147,377 | $17.9M |
| ARRYARRAY BIOPHARMA INC | 1,752,599 | $12.8M |
| JNJJOHNSON & JOHNSON | 37,023 | $9.1M |
| UTHRUNITED THERAPEUTICS Corp | 7,444 | $4.4M |
| CORCencora Inc. | 10,190 | $3.2M |
| CAHCardinal Health Inc. | 11,605 | $2.4M |
| AMGNAMGEN INC | 5,506 | $1.9M |
| PFEPFIZER INC | 49,998 | $1.4M |
| RPRXRoyalty Pharma plc | 25,065 | $1.2M |
| ABTABBOTT LABORATORIES | 7,513 | $773K |
| PMPhilip Morris International Inc | 3,750 | $623K |
| REGNREGENERON PHARMACEUTICALS, INC. | 678 | $526K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,221 | $332K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.